nodes	percent_of_prediction	percent_of_DWPC	metapath
Clozapine—HRH3—attention deficit hyperactivity disorder	0.167	0.217	CbGaD
Clozapine—ADRA2C—attention deficit hyperactivity disorder	0.153	0.198	CbGaD
Clozapine—DRD4—attention deficit hyperactivity disorder	0.0827	0.107	CbGaD
Clozapine—HTR1B—attention deficit hyperactivity disorder	0.0735	0.0955	CbGaD
Clozapine—DRD3—attention deficit hyperactivity disorder	0.0713	0.0927	CbGaD
Clozapine—DRD1—attention deficit hyperactivity disorder	0.07	0.091	CbGaD
Clozapine—ADRA2A—attention deficit hyperactivity disorder	0.0651	0.0845	CbGaD
Clozapine—DRD2—attention deficit hyperactivity disorder	0.0494	0.0641	CbGaD
Clozapine—HTR2A—attention deficit hyperactivity disorder	0.0382	0.0496	CbGaD
Clozapine—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00349	0.054	CbGeAlD
Clozapine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00217	0.0336	CbGeAlD
Clozapine—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00185	0.0287	CbGeAlD
Clozapine—HRH3—forebrain—attention deficit hyperactivity disorder	0.00139	0.0215	CbGeAlD
Clozapine—HTR1E—forebrain—attention deficit hyperactivity disorder	0.00118	0.0183	CbGeAlD
Clozapine—CALY—midbrain—attention deficit hyperactivity disorder	0.00118	0.0183	CbGeAlD
Clozapine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00116	0.0179	CbGeAlD
Clozapine—CALY—nervous system—attention deficit hyperactivity disorder	0.00097	0.015	CbGeAlD
Clozapine—CALY—central nervous system—attention deficit hyperactivity disorder	0.000934	0.0145	CbGeAlD
Clozapine—HTR6—forebrain—attention deficit hyperactivity disorder	0.000929	0.0144	CbGeAlD
Clozapine—CALY—cerebellum—attention deficit hyperactivity disorder	0.000913	0.0141	CbGeAlD
Clozapine—HRH3—nervous system—attention deficit hyperactivity disorder	0.000756	0.0117	CbGeAlD
Clozapine—CALY—brain—attention deficit hyperactivity disorder	0.000741	0.0115	CbGeAlD
Clozapine—HRH3—central nervous system—attention deficit hyperactivity disorder	0.000727	0.0113	CbGeAlD
Clozapine—HRH3—cerebellum—attention deficit hyperactivity disorder	0.000711	0.011	CbGeAlD
Clozapine—H1F0—forebrain—attention deficit hyperactivity disorder	0.0007	0.0108	CbGeAlD
Clozapine—DRD1—forebrain—attention deficit hyperactivity disorder	0.000691	0.0107	CbGeAlD
Clozapine—HTR3A—forebrain—attention deficit hyperactivity disorder	0.000667	0.0103	CbGeAlD
Clozapine—HTR1E—nervous system—attention deficit hyperactivity disorder	0.000642	0.00994	CbGeAlD
Clozapine—HTR1E—central nervous system—attention deficit hyperactivity disorder	0.000619	0.00957	CbGeAlD
Clozapine—H1F0—cardiovascular system—attention deficit hyperactivity disorder	0.000592	0.00916	CbGeAlD
Clozapine—HRH3—brain—attention deficit hyperactivity disorder	0.000578	0.00894	CbGeAlD
Clozapine—DRD4—brain—attention deficit hyperactivity disorder	0.000569	0.00881	CbGeAlD
Clozapine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.000563	0.00872	CbGeAlD
Clozapine—HTR1B—forebrain—attention deficit hyperactivity disorder	0.00056	0.00866	CbGeAlD
Clozapine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.000557	0.00862	CbGeAlD
Clozapine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.000542	0.00839	CbGeAlD
Clozapine—HTR1D—forebrain—attention deficit hyperactivity disorder	0.000542	0.00839	CbGeAlD
Clozapine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000537	0.00831	CbGeAlD
Clozapine—DRD3—nervous system—attention deficit hyperactivity disorder	0.000524	0.00811	CbGeAlD
Clozapine—FMO3—nervous system—attention deficit hyperactivity disorder	0.000518	0.00801	CbGeAlD
Clozapine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.000507	0.00784	CbGeAlD
Clozapine—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000504	0.0078	CbGeAlD
Clozapine—HTR6—nervous system—attention deficit hyperactivity disorder	0.000504	0.0078	CbGeAlD
Clozapine—FMO3—central nervous system—attention deficit hyperactivity disorder	0.000499	0.00772	CbGeAlD
Clozapine—HTR1E—brain—attention deficit hyperactivity disorder	0.000491	0.0076	CbGeAlD
Clozapine—HTR6—central nervous system—attention deficit hyperactivity disorder	0.000485	0.00751	CbGeAlD
Clozapine—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000473	0.00733	CbGeAlD
Clozapine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.000471	0.00729	CbGeAlD
Clozapine—H1F0—midbrain—attention deficit hyperactivity disorder	0.000462	0.00715	CbGeAlD
Clozapine—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.000458	0.00709	CbGeAlD
Clozapine—DRD1—midbrain—attention deficit hyperactivity disorder	0.000456	0.00706	CbGeAlD
Clozapine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.000454	0.00702	CbGeAlD
Clozapine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000452	0.00699	CbGeAlD
Clozapine—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00044	0.00681	CbGeAlD
Clozapine—HTR7—forebrain—attention deficit hyperactivity disorder	0.000432	0.00668	CbGeAlD
Clozapine—CHRM4—brain—attention deficit hyperactivity disorder	0.000431	0.00666	CbGeAlD
Clozapine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.000429	0.00663	CbGeAlD
Clozapine—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.000424	0.00656	CbGeAlD
Clozapine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000416	0.00644	CbGeAlD
Clozapine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000408	0.00632	CbGeAlD
Clozapine—CYP1B1—cardiovascular system—attention deficit hyperactivity disorder	0.000406	0.00629	CbGeAlD
Clozapine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000402	0.00623	CbGeAlD
Clozapine—DRD3—brain—attention deficit hyperactivity disorder	0.0004	0.0062	CbGeAlD
Clozapine—FMO3—brain—attention deficit hyperactivity disorder	0.000396	0.00613	CbGeAlD
Clozapine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000387	0.00599	CbGeAlD
Clozapine—HTR6—brain—attention deficit hyperactivity disorder	0.000385	0.00596	CbGeAlD
Clozapine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000382	0.00591	CbGeAlD
Clozapine—H1F0—nervous system—attention deficit hyperactivity disorder	0.00038	0.00588	CbGeAlD
Clozapine—DRD1—nervous system—attention deficit hyperactivity disorder	0.000375	0.0058	CbGeAlD
Clozapine—HTR1B—midbrain—attention deficit hyperactivity disorder	0.00037	0.00572	CbGeAlD
Clozapine—H1F0—central nervous system—attention deficit hyperactivity disorder	0.000366	0.00566	CbGeAlD
Clozapine—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000365	0.00565	CbGeAlD
Clozapine—HTR3A—nervous system—attention deficit hyperactivity disorder	0.000362	0.00561	CbGeAlD
Clozapine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000361	0.00559	CbGeAlD
Clozapine—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000358	0.00554	CbGeAlD
Clozapine—H1F0—cerebellum—attention deficit hyperactivity disorder	0.000357	0.00553	CbGeAlD
Clozapine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000354	0.00548	CbGeAlD
Clozapine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000352	0.00545	CbGeAlD
Clozapine—HTR3A—central nervous system—attention deficit hyperactivity disorder	0.000349	0.0054	CbGeAlD
Clozapine—CHRM5—brain—attention deficit hyperactivity disorder	0.000337	0.00521	CbGeAlD
Clozapine—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.000335	0.00518	CbGeAlD
Clozapine—HRH1—forebrain—attention deficit hyperactivity disorder	0.000322	0.00499	CbGeAlD
Clozapine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000317	0.0049	CbGeAlD
Clozapine—ADRA1B—brain—attention deficit hyperactivity disorder	0.000308	0.00476	CbGeAlD
Clozapine—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000304	0.0047	CbGeAlD
Clozapine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000302	0.00468	CbGeAlD
Clozapine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000298	0.00462	CbGeAlD
Clozapine—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000294	0.00455	CbGeAlD
Clozapine—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000293	0.00453	CbGeAlD
Clozapine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000291	0.00451	CbGeAlD
Clozapine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000291	0.0045	CbGeAlD
Clozapine—H1F0—brain—attention deficit hyperactivity disorder	0.00029	0.00449	CbGeAlD
Clozapine—DRD1—brain—attention deficit hyperactivity disorder	0.000287	0.00444	CbGeAlD
Clozapine—HTR7—midbrain—attention deficit hyperactivity disorder	0.000285	0.00441	CbGeAlD
Clozapine—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000283	0.00438	CbGeAlD
Clozapine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.00028	0.00434	CbGeAlD
Clozapine—Ziprasidone—DRD5—attention deficit hyperactivity disorder	0.000278	0.0398	CrCbGaD
Clozapine—HTR3A—brain—attention deficit hyperactivity disorder	0.000277	0.00428	CbGeAlD
Clozapine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000276	0.00428	CbGeAlD
Clozapine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.000275	0.00426	CbGeAlD
Clozapine—CYP2A6—brain—attention deficit hyperactivity disorder	0.000272	0.00421	CbGeAlD
Clozapine—DRD2—midbrain—attention deficit hyperactivity disorder	0.00027	0.00417	CbGeAlD
Clozapine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000269	0.00417	CbGeAlD
Clozapine—Azelastine—HRH3—attention deficit hyperactivity disorder	0.000269	0.0385	CrCbGaD
Clozapine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.000265	0.0041	CbGeAlD
Clozapine—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000262	0.00406	CbGeAlD
Clozapine—Ziprasidone—ADRA2C—attention deficit hyperactivity disorder	0.000262	0.0375	CrCbGaD
Clozapine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000262	0.00405	CbGeAlD
Clozapine—CYP1B1—nervous system—attention deficit hyperactivity disorder	0.000261	0.00404	CbGeAlD
Clozapine—CYP1B1—central nervous system—attention deficit hyperactivity disorder	0.000251	0.00389	CbGeAlD
Clozapine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.000246	0.00381	CbGeAlD
Clozapine—CYP1B1—cerebellum—attention deficit hyperactivity disorder	0.000245	0.0038	CbGeAlD
Clozapine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000245	0.0038	CbGeAlD
Clozapine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000245	0.0038	CbGeAlD
Clozapine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.000237	0.00367	CbGeAlD
Clozapine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000236	0.00365	CbGeAlD
Clozapine—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.000235	0.0336	CrCbGaD
Clozapine—HTR7—nervous system—attention deficit hyperactivity disorder	0.000234	0.00363	CbGeAlD
Clozapine—HTR1B—brain—attention deficit hyperactivity disorder	0.000232	0.00359	CbGeAlD
Clozapine—CHRM2—brain—attention deficit hyperactivity disorder	0.000231	0.00358	CbGeAlD
Clozapine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000231	0.00357	CbGeAlD
Clozapine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000228	0.00352	CbGeAlD
Clozapine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000226	0.0035	CbGeAlD
Clozapine—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000226	0.00349	CbGeAlD
Clozapine—HTR1D—brain—attention deficit hyperactivity disorder	0.000225	0.00348	CbGeAlD
Clozapine—Olanzapine—DRD5—attention deficit hyperactivity disorder	0.000224	0.032	CrCbGaD
Clozapine—HTR2C—brain—attention deficit hyperactivity disorder	0.000223	0.00345	CbGeAlD
Clozapine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000222	0.00343	CbGeAlD
Clozapine—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000221	0.00341	CbGeAlD
Clozapine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000218	0.00337	CbGeAlD
Clozapine—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000215	0.00333	CbGeAlD
Clozapine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000213	0.0033	CbGeAlD
Clozapine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000213	0.00329	CbGeAlD
Clozapine—Olanzapine—ADRA2C—attention deficit hyperactivity disorder	0.000211	0.0302	CrCbGaD
Clozapine—CHRM1—brain—attention deficit hyperactivity disorder	0.00021	0.00325	CbGeAlD
Clozapine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000209	0.00324	CbGeAlD
Clozapine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000208	0.00323	CbGeAlD
Clozapine—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000207	0.00321	CbGeAlD
Clozapine—Oxazepam—GABRQ—attention deficit hyperactivity disorder	0.000204	0.0292	CrCbGaD
Clozapine—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000203	0.00314	CbGeAlD
Clozapine—Temazepam—GABRQ—attention deficit hyperactivity disorder	0.000201	0.0288	CrCbGaD
Clozapine—CYP1B1—brain—attention deficit hyperactivity disorder	0.000199	0.00309	CbGeAlD
Clozapine—CHRM3—brain—attention deficit hyperactivity disorder	0.000188	0.00291	CbGeAlD
Clozapine—HTR1A—brain—attention deficit hyperactivity disorder	0.000187	0.0029	CbGeAlD
Clozapine—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.000184	0.00285	CbGeAlD
Clozapine—HTR7—brain—attention deficit hyperactivity disorder	0.000179	0.00277	CbGeAlD
Clozapine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000178	0.00275	CbGeAlD
Clozapine—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.000177	0.00275	CbGeAlD
Clozapine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000176	0.00273	CbGeAlD
Clozapine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000175	0.00271	CbGeAlD
Clozapine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000173	0.00267	CbGeAlD
Clozapine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000172	0.00266	CbGeAlD
Clozapine—DRD2—brain—attention deficit hyperactivity disorder	0.000169	0.00262	CbGeAlD
Clozapine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000168	0.00261	CbGeAlD
Clozapine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000168	0.0026	CbGeAlD
Clozapine—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.000167	0.0239	CrCbGaD
Clozapine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000165	0.00256	CbGeAlD
Clozapine—ADRA2C—brain—attention deficit hyperactivity disorder	0.000165	0.00255	CbGeAlD
Clozapine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000162	0.00251	CbGeAlD
Clozapine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000162	0.0025	CbGeAlD
Clozapine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000158	0.00245	CbGeAlD
Clozapine—Mazindol—SLC6A3—attention deficit hyperactivity disorder	0.000158	0.0227	CrCbGaD
Clozapine—CYP2C8—brain—attention deficit hyperactivity disorder	0.000153	0.00236	CbGeAlD
Clozapine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000149	0.00231	CbGeAlD
Clozapine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000146	0.00226	CbGeAlD
Clozapine—Ziprasidone—DRD4—attention deficit hyperactivity disorder	0.000142	0.0204	CrCbGaD
Clozapine—CYP1A1—brain—attention deficit hyperactivity disorder	0.000141	0.00218	CbGeAlD
Clozapine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000141	0.00218	CbGeAlD
Clozapine—Loxapine—DRD5—attention deficit hyperactivity disorder	0.000139	0.0199	CrCbGaD
Clozapine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000138	0.00213	CbGeAlD
Clozapine—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.000136	0.0194	CrCbGaD
Clozapine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000135	0.00209	CbGeAlD
Clozapine—HRH1—brain—attention deficit hyperactivity disorder	0.000134	0.00207	CbGeAlD
Clozapine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000133	0.00206	CbGeAlD
Clozapine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000131	0.00203	CbGeAlD
Clozapine—Loxapine—ADRA2C—attention deficit hyperactivity disorder	0.000131	0.0188	CrCbGaD
Clozapine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00013	0.00202	CbGeAlD
Clozapine—CYP2E1—brain—attention deficit hyperactivity disorder	0.000129	0.00199	CbGeAlD
Clozapine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000128	0.00198	CbGeAlD
Clozapine—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.000128	0.0183	CrCbGaD
Clozapine—Ziprasidone—HTR1B—attention deficit hyperactivity disorder	0.000126	0.0181	CrCbGaD
Clozapine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000125	0.00194	CbGeAlD
Clozapine—Ziprasidone—DRD3—attention deficit hyperactivity disorder	0.000123	0.0176	CrCbGaD
Clozapine—Ziprasidone—DRD1—attention deficit hyperactivity disorder	0.00012	0.0172	CrCbGaD
Clozapine—Mazindol—SLC6A4—attention deficit hyperactivity disorder	0.000118	0.0169	CrCbGaD
Clozapine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000116	0.0018	CbGeAlD
Clozapine—Olanzapine—DRD4—attention deficit hyperactivity disorder	0.000114	0.0164	CrCbGaD
Clozapine—Ziprasidone—ADRA2A—attention deficit hyperactivity disorder	0.000112	0.016	CrCbGaD
Clozapine—HTR2A—brain—attention deficit hyperactivity disorder	0.000112	0.00173	CbGeAlD
Clozapine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000102	0.00157	CbGeAlD
Clozapine—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.000102	0.0146	CrCbGaD
Clozapine—Olanzapine—HTR1B—attention deficit hyperactivity disorder	0.000102	0.0146	CrCbGaD
Clozapine—Olanzapine—DRD3—attention deficit hyperactivity disorder	9.86e-05	0.0141	CrCbGaD
Clozapine—Olanzapine—DRD1—attention deficit hyperactivity disorder	9.68e-05	0.0139	CrCbGaD
Clozapine—ABCB1—nervous system—attention deficit hyperactivity disorder	9.58e-05	0.00148	CbGeAlD
Clozapine—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	9.45e-05	0.0135	CrCbGaD
Clozapine—ABCB1—central nervous system—attention deficit hyperactivity disorder	9.22e-05	0.00143	CbGeAlD
Clozapine—Amoxapine—DRD4—attention deficit hyperactivity disorder	9.1e-05	0.013	CrCbGaD
Clozapine—ABCB1—cerebellum—attention deficit hyperactivity disorder	9.01e-05	0.00139	CbGeAlD
Clozapine—Olanzapine—ADRA2A—attention deficit hyperactivity disorder	9e-05	0.0129	CrCbGaD
Clozapine—Thiothixene—DRD1—attention deficit hyperactivity disorder	8.76e-05	0.0126	CrCbGaD
Clozapine—Trazodone—ADRA2A—attention deficit hyperactivity disorder	8.69e-05	0.0125	CrCbGaD
Clozapine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	8.53e-05	0.0122	CrCbGaD
Clozapine—Ziprasidone—SLC6A4—attention deficit hyperactivity disorder	8.53e-05	0.0122	CrCbGaD
Clozapine—Ziprasidone—DRD2—attention deficit hyperactivity disorder	8.48e-05	0.0122	CrCbGaD
Clozapine—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	8.14e-05	0.0117	CrCbGaD
Clozapine—Amoxapine—HTR1B—attention deficit hyperactivity disorder	8.09e-05	0.0116	CrCbGaD
Clozapine—Amoxapine—DRD3—attention deficit hyperactivity disorder	7.85e-05	0.0112	CrCbGaD
Clozapine—Amoxapine—DRD1—attention deficit hyperactivity disorder	7.7e-05	0.011	CrCbGaD
Clozapine—ABCB1—brain—attention deficit hyperactivity disorder	7.32e-05	0.00113	CbGeAlD
Clozapine—Amoxapine—SLC6A3—attention deficit hyperactivity disorder	7.3e-05	0.0105	CrCbGaD
Clozapine—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	7.17e-05	0.0103	CrCbGaD
Clozapine—Amoxapine—ADRA2A—attention deficit hyperactivity disorder	7.16e-05	0.0103	CrCbGaD
Clozapine—Loxapine—DRD4—attention deficit hyperactivity disorder	7.11e-05	0.0102	CrCbGaD
Clozapine—Cyproheptadine—DRD2—attention deficit hyperactivity disorder	7.05e-05	0.0101	CrCbGaD
Clozapine—Quetiapine—DRD4—attention deficit hyperactivity disorder	6.94e-05	0.00994	CrCbGaD
Clozapine—Olanzapine—DRD2—attention deficit hyperactivity disorder	6.82e-05	0.00978	CrCbGaD
Clozapine—Trazodone—SLC6A4—attention deficit hyperactivity disorder	6.63e-05	0.0095	CrCbGaD
Clozapine—Ziprasidone—HTR2A—attention deficit hyperactivity disorder	6.55e-05	0.00939	CrCbGaD
Clozapine—Loxapine—HTR1B—attention deficit hyperactivity disorder	6.31e-05	0.00905	CrCbGaD
Clozapine—Thiothixene—DRD2—attention deficit hyperactivity disorder	6.18e-05	0.00886	CrCbGaD
Clozapine—Quetiapine—HTR1B—attention deficit hyperactivity disorder	6.16e-05	0.00883	CrCbGaD
Clozapine—Loxapine—DRD3—attention deficit hyperactivity disorder	6.13e-05	0.00879	CrCbGaD
Clozapine—Loxapine—DRD1—attention deficit hyperactivity disorder	6.02e-05	0.00862	CrCbGaD
Clozapine—Quetiapine—DRD3—attention deficit hyperactivity disorder	5.98e-05	0.00858	CrCbGaD
Clozapine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	5.91e-05	0.00846	CrCbGaD
Clozapine—Quetiapine—DRD1—attention deficit hyperactivity disorder	5.87e-05	0.00842	CrCbGaD
Clozapine—Loxapine—SLC6A3—attention deficit hyperactivity disorder	5.7e-05	0.00818	CrCbGaD
Clozapine—Loxapine—ADRA2A—attention deficit hyperactivity disorder	5.59e-05	0.00801	CrCbGaD
Clozapine—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	5.54e-05	0.00794	CrCbGaD
Clozapine—Amoxapine—SLC6A4—attention deficit hyperactivity disorder	5.46e-05	0.00783	CrCbGaD
Clozapine—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	5.46e-05	0.00782	CrCbGaD
Clozapine—Cyproheptadine—HTR2A—attention deficit hyperactivity disorder	5.45e-05	0.0078	CrCbGaD
Clozapine—Amoxapine—DRD2—attention deficit hyperactivity disorder	5.43e-05	0.00778	CrCbGaD
Clozapine—Olanzapine—HTR2A—attention deficit hyperactivity disorder	5.27e-05	0.00756	CrCbGaD
Clozapine—Trazodone—HTR2A—attention deficit hyperactivity disorder	5.1e-05	0.0073	CrCbGaD
Clozapine—Thiothixene—HTR2A—attention deficit hyperactivity disorder	4.77e-05	0.00684	CrCbGaD
Clozapine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	4.27e-05	0.00612	CrCbGaD
Clozapine—Loxapine—SLC6A4—attention deficit hyperactivity disorder	4.27e-05	0.00611	CrCbGaD
Clozapine—Loxapine—DRD2—attention deficit hyperactivity disorder	4.24e-05	0.00608	CrCbGaD
Clozapine—Amoxapine—HTR2A—attention deficit hyperactivity disorder	4.2e-05	0.00602	CrCbGaD
Clozapine—Quetiapine—DRD2—attention deficit hyperactivity disorder	4.14e-05	0.00593	CrCbGaD
Clozapine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	3.3e-05	0.00473	CrCbGaD
Clozapine—Loxapine—HTR2A—attention deficit hyperactivity disorder	3.28e-05	0.0047	CrCbGaD
Clozapine—Quetiapine—HTR2A—attention deficit hyperactivity disorder	3.2e-05	0.00459	CrCbGaD
Clozapine—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.48e-06	3.46e-05	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.48e-06	3.46e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.47e-06	3.45e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.46e-06	3.44e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.44e-06	3.43e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.4e-06	3.41e-05	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.4e-06	3.41e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.37e-06	3.39e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	5.36e-06	3.38e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.36e-06	3.38e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.3e-06	3.34e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.29e-06	3.34e-05	CbGpPWpGaD
Clozapine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.29e-06	3.34e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.29e-06	3.34e-05	CbGpPWpGaD
Clozapine—CYP1B1—Metabolism—COMT—attention deficit hyperactivity disorder	5.28e-06	3.33e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	5.28e-06	3.33e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.27e-06	3.32e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.24e-06	3.31e-05	CbGpPWpGaD
Clozapine—CYP1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.24e-06	3.31e-05	CbGpPWpGaD
Clozapine—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	5.23e-06	3.3e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.21e-06	3.29e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.2e-06	3.28e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.2e-06	3.28e-05	CbGpPWpGaD
Clozapine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.19e-06	3.28e-05	CbGpPWpGaD
Clozapine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.18e-06	3.27e-05	CbGpPWpGaD
Clozapine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.16e-06	3.26e-05	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.14e-06	3.24e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.13e-06	3.24e-05	CbGpPWpGaD
Clozapine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.11e-06	3.22e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.1e-06	3.22e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.1e-06	3.22e-05	CbGpPWpGaD
Clozapine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.1e-06	3.22e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.1e-06	3.22e-05	CbGpPWpGaD
Clozapine—CYP1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.08e-06	3.21e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.08e-06	3.2e-05	CbGpPWpGaD
Clozapine—FMO3—Metabolism—EP300—attention deficit hyperactivity disorder	5.04e-06	3.18e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.02e-06	3.17e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.02e-06	3.16e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.99e-06	3.15e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.98e-06	3.14e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.95e-06	3.13e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.95e-06	3.13e-05	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.95e-06	3.12e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.94e-06	3.12e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.93e-06	3.11e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	4.92e-06	3.1e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.92e-06	3.1e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.91e-06	3.1e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.9e-06	3.09e-05	CbGpPWpGaD
Clozapine—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	4.89e-06	3.08e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.89e-06	3.08e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.87e-06	3.07e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.86e-06	3.07e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.85e-06	3.06e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.85e-06	3.06e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	4.84e-06	3.05e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.81e-06	3.03e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.8e-06	3.03e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.79e-06	3.03e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.79e-06	3.02e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.78e-06	3.02e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.78e-06	3.01e-05	CbGpPWpGaD
Clozapine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.74e-06	2.99e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.72e-06	2.98e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.72e-06	2.98e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.7e-06	2.97e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.69e-06	2.96e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.64e-06	2.93e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.63e-06	2.92e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.63e-06	2.92e-05	CbGpPWpGaD
Clozapine—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	4.62e-06	2.92e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.61e-06	2.91e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.59e-06	2.9e-05	CbGpPWpGaD
Clozapine—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	4.59e-06	2.9e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.55e-06	2.87e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.55e-06	2.87e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.54e-06	2.87e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.53e-06	2.86e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.51e-06	2.85e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.5e-06	2.84e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.48e-06	2.83e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.47e-06	2.82e-05	CbGpPWpGaD
Clozapine—HRH3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.47e-06	2.82e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.47e-06	2.82e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.46e-06	2.81e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.45e-06	2.81e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.41e-06	2.78e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.4e-06	2.78e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.4e-06	2.78e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.39e-06	2.77e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	4.39e-06	2.77e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.39e-06	2.77e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.38e-06	2.77e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.37e-06	2.76e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.37e-06	2.76e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.36e-06	2.75e-05	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	4.36e-06	2.75e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.35e-06	2.74e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.33e-06	2.73e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.33e-06	2.73e-05	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	4.33e-06	2.73e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.33e-06	2.73e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.33e-06	2.73e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.32e-06	2.73e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	4.32e-06	2.72e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.32e-06	2.72e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.31e-06	2.72e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.3e-06	2.71e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.3e-06	2.71e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.29e-06	2.71e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	4.28e-06	2.7e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.28e-06	2.7e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.28e-06	2.7e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.27e-06	2.69e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.26e-06	2.69e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.25e-06	2.68e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.24e-06	2.68e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.24e-06	2.68e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.24e-06	2.68e-05	CbGpPWpGaD
Clozapine—UGT1A4—Metabolism—EP300—attention deficit hyperactivity disorder	4.22e-06	2.67e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	4.21e-06	2.66e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.2e-06	2.65e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.19e-06	2.64e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.18e-06	2.63e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.14e-06	2.61e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.12e-06	2.6e-05	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	4.09e-06	2.58e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.08e-06	2.58e-05	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	4.06e-06	2.56e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	4.04e-06	2.55e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.04e-06	2.55e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.01e-06	2.53e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.01e-06	2.53e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	4e-06	2.53e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	4e-06	2.53e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.99e-06	2.52e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.98e-06	2.51e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	3.97e-06	2.51e-05	CbGpPWpGaD
Clozapine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	3.97e-06	2.5e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.97e-06	2.5e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.95e-06	2.49e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.94e-06	2.49e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	3.94e-06	2.48e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.93e-06	2.48e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.92e-06	2.47e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.91e-06	2.47e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.9e-06	2.46e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.89e-06	2.46e-05	CbGpPWpGaD
Clozapine—HRH4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.89e-06	2.45e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.82e-06	2.41e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.76e-06	2.37e-05	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	3.75e-06	2.37e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.74e-06	2.36e-05	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	3.73e-06	2.35e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.71e-06	2.34e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.69e-06	2.33e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.66e-06	2.31e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.63e-06	2.29e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.51e-06	2.21e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	3.45e-06	2.17e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.42e-06	2.16e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	3.42e-06	2.16e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	3.42e-06	2.16e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.42e-06	2.16e-05	CbGpPWpGaD
Clozapine—HTR1E—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.39e-06	2.14e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	3.36e-06	2.12e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.35e-06	2.11e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.34e-06	2.11e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.26e-06	2.06e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	3.25e-06	2.05e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.23e-06	2.04e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.23e-06	2.04e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	3.23e-06	2.04e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.22e-06	2.03e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.2e-06	2.02e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.13e-06	1.97e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.13e-06	1.97e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.13e-06	1.97e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.08e-06	1.94e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.07e-06	1.94e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.05e-06	1.92e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	2.98e-06	1.88e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	2.96e-06	1.87e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.87e-06	1.81e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.84e-06	1.79e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.79e-06	1.76e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.78e-06	1.75e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.77e-06	1.75e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.74e-06	1.73e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.73e-06	1.73e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.73e-06	1.73e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	2.66e-06	1.68e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	2.64e-06	1.67e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	2.64e-06	1.67e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.64e-06	1.67e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.6e-06	1.64e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	2.6e-06	1.64e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	2.6e-06	1.64e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.58e-06	1.63e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.56e-06	1.62e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.54e-06	1.6e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	2.45e-06	1.54e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	2.43e-06	1.53e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	2.42e-06	1.53e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.41e-06	1.52e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	2.41e-06	1.52e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.33e-06	1.47e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.31e-06	1.46e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.31e-06	1.46e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.3e-06	1.45e-05	CbGpPWpGaD
Clozapine—CYP1B1—Metabolism—EP300—attention deficit hyperactivity disorder	2.26e-06	1.43e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.25e-06	1.42e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.21e-06	1.4e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.18e-06	1.38e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.11e-06	1.33e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.09e-06	1.32e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	2.07e-06	1.31e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.06e-06	1.3e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.01e-06	1.27e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2e-06	1.26e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.99e-06	1.26e-05	CbGpPWpGaD
Clozapine—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	1.98e-06	1.25e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.96e-06	1.24e-05	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	1.87e-06	1.18e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.77e-06	1.12e-05	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	1.75e-06	1.11e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.71e-06	1.08e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.7e-06	1.07e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.66e-06	1.05e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.63e-06	1.03e-05	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	1.61e-06	1.02e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	1.6e-06	1.01e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	1.59e-06	1e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.5e-06	9.49e-06	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.48e-06	9.33e-06	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	1.48e-06	9.33e-06	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.48e-06	9.31e-06	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.47e-06	9.28e-06	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.47e-06	9.25e-06	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.45e-06	9.17e-06	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.45e-06	9.14e-06	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	1.39e-06	8.79e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.35e-06	8.49e-06	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	1.28e-06	8.06e-06	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	1.14e-06	7.2e-06	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	1.11e-06	7.02e-06	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.05e-06	6.62e-06	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	1.04e-06	6.56e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	8.89e-07	5.61e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	6.86e-07	4.33e-06	CbGpPWpGaD
